EUROPACE, vol.21, no.7, pp.1013-1022, 2019 (SCI-Expanded)
Aims In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs). Contemporary European data on AF thromboprophylaxis are needed.